Financials Cabot Corporation

Equities

CBT

US1270551013

Specialty Chemicals

Real-time Estimate Cboe BZX 02:22:24 2024-05-20 pm EDT 5-day change 1st Jan Change
102.8 USD +0.38% Intraday chart for Cabot Corporation +0.61% +23.10%

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,619 2,034 2,843 3,597 3,875 5,658 - -
Enterprise Value (EV) 1 3,514 2,998 3,837 4,834 4,913 6,605 6,572 6,538
P/E ratio 17.2 x -8.56 x 11.5 x - - - - -
Yield 3% 3.89% 2.79% 2.32% 2.22% 1.65% 1.79% 1.94%
Capitalization / Revenue 0.78 x 0.78 x 0.83 x 0.83 x 0.99 x 1.42 x 1.33 x 1.28 x
EV / Revenue 1.05 x 1.15 x 1.13 x 1.12 x 1.25 x 1.65 x 1.55 x 1.48 x
EV / EBITDA 6.49 x 7.51 x 5.88 x 6.64 x 7.07 x 8.4 x 7.71 x 7.26 x
EV / FCF 25.6 x 16.9 x 61.9 x -43.5 x 14 x 19 x 32.8 x 29.3 x
FCF Yield 3.9% 5.9% 1.62% -2.3% 7.14% 5.25% 3.05% 3.41%
Price to Book 2.59 x 2.94 x 3 x 4.02 x - 3.85 x 3.44 x 3.03 x
Nbr of stocks (in thousands) 57,783 56,462 56,724 56,299 55,937 55,258 - -
Reference price 2 45.32 36.03 50.12 63.89 69.27 102.4 102.4 102.4
Announcement Date 11/4/19 11/23/20 11/8/21 11/7/22 11/6/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,337 2,614 3,409 4,321 3,931 3,993 4,253 4,405
EBITDA 1 541 399 652 728 695 785.9 852.4 900
EBIT 1 394 242 492 583 553 627.6 697.5 738.4
Operating Margin 11.81% 9.26% 14.43% 13.49% 14.07% 15.72% 16.4% 16.76%
Earnings before Tax (EBT) 1 255 -33 406 335 451 534.7 611.5 677
Net income 157 -238 250 209 445 - - -
Net margin 4.7% -9.1% 7.33% 4.84% 11.32% - - -
EPS 2.630 -4.210 4.340 - - - - -
Free Cash Flow 1 137 177 62 -111 351 347 200.5 223
FCF margin 4.11% 6.77% 1.82% -2.57% 8.93% 8.69% 4.71% 5.06%
FCF Conversion (EBITDA) 25.32% 44.36% 9.51% - 50.5% 44.15% 23.52% 24.78%
FCF Conversion (Net income) 87.26% - 24.8% - 78.88% - - -
Dividend per Share 2 1.360 1.400 1.400 1.480 1.540 1.686 1.836 1.987
Announcement Date 11/4/19 11/23/20 11/8/21 11/7/22 11/6/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 968 1,092 1,149 1,112 965 1,033 968 965 958 1,019 998.1 1,007 1,041 1,092 1,048
EBITDA 1 162 191 197 178 142 170 189 194 181 199 201.2 203.9 212.7 223 213
EBIT 1 123 155 162 143 108 134 153 158 140 162 161.2 162.6 173.3 182.7 172
Operating Margin 12.71% 14.19% 14.1% 12.86% 11.19% 12.97% 15.81% 16.37% 14.61% 15.9% 16.15% 16.14% 16.65% 16.73% 16.41%
Earnings before Tax (EBT) 1 -93 147 152 129 84 110 130 127 - 142 132.6 140.8 - - -
Net income -89 107 97 94 54 75 82 234 - - - - - - -
Net margin -9.19% 9.8% 8.44% 8.45% 5.6% 7.26% 8.47% 24.25% - - - - - - -
EPS -1.570 1.840 - - 0.9300 1.290 1.430 - - - - - - - -
Dividend per Share 2 0.3700 0.3700 0.3700 0.3700 0.3700 - 0.4000 - - - 0.4325 0.4758 0.4758 0.4758 0.4758
Announcement Date 1/31/22 5/2/22 8/8/22 11/7/22 2/9/23 5/8/23 8/7/23 11/6/23 2/5/24 5/6/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 895 964 994 1,237 1,038 947 914 880
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.654 x 2.416 x 1.525 x 1.699 x 1.494 x 1.205 x 1.072 x 0.9774 x
Free Cash Flow 1 137 177 62 -111 351 347 201 223
ROE (net income / shareholders' equity) 21.4% 13.9% 34.8% 39% 28.1% 27.6% 27.1% 26%
ROA (Net income/ Total Assets) 7.36% 4.07% 9.37% 10.5% 8.53% 10.2% 10.8% 11.3%
Assets 2,133 -5,848 2,668 1,983 5,218 - - -
Book Value Per Share 2 17.50 12.20 16.70 15.90 - 26.60 29.80 33.80
Cash Flow per Share 2 6.140 6.660 4.520 1.760 10.50 9.120 9.880 10.30
Capex 1 224 200 195 211 244 241 285 294
Capex / Sales 6.71% 7.65% 5.72% 4.88% 6.21% 6.03% 6.7% 6.67%
Announcement Date 11/4/19 11/23/20 11/8/21 11/7/22 11/6/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
102.4 USD
Average target price
104.5 USD
Spread / Average Target
+2.05%
Consensus
  1. Stock Market
  2. Equities
  3. CBT Stock
  4. Financials Cabot Corporation
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW